AI Summary & Key Takeaways
AI InsightA few months later after the removal of the implant she reported an improvement of the facial paralysis that had started 4 months after the second insertion of Implanon®.
📌 3 Key Takeaways
Abstract
Etonogestrel single rod subdermal implant provides an effective contraceptive protection for up to 3 years with no reported pregnancies in clinical trials Unfortunately, similar to other long-term progestinonly contraceptives, Implanon® leads to irregular uterine bleeding in the majority of users. Bleeding disturbances are the main reason for discontinuation of therapy. Other reported nonmenstrual adverse effects of Implanon® include headache, acne, weight gain, and mastalgia. In this paper we do report a case of facial paralysis during the use of Implanon®. A 35-year-old woman with an Implanon® contraceptive device in situ presented with amenore. The implant had been inserted 4 years previously which was changed one year before the removal. Because of the patient being amenorrhoeic for one year, the Implanon® was removed in January 2010. A few months later after the removal of the implant she reported an improvement of the facial paralysis that had started 4 months after the second insertion of Implanon®.
Özet
Etonogestrel tek çubuklu subdermal implant, 3 yılın üzerinde etkili koruma sağlar. Yapılan klinik çalışmalarda bildirilmiş gebelik bulunmamaktadır. Ne yazık ki, sadece progesteron içeren diğer uzun etkili konrtaseptiflere benzer şekilde, düzensiz uterin kanamalara neden olur. Kanama düzensizlikleri tedaviyi bırakmanın en önemli sebebidir. Bildirilen diğer yan etkiler; baş ağrısı, akne, kilo artışı ve mastaljidir. Literatürde fasial paralizi şeklinde bir yan etkisi hiç görülmemiştir. Bu makalede, Implanon kullanımına bağlı gelişen bir fasial paralizi olgusu sunulmaktadır.